Hosted on MSN

STAAR Surgical Faces Legal Challenges in Alcon Merger

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Staar Surgical ( (STAA)) has provided an ...
The Bakersfield Californian

STAAR Surgical: Independent Industry Analysts Recognize Merits of Alcon Merger, the Value It Provides, and the Downside Risks Facing STAAR on Standalone Basis

STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer ® Lenses (EVO ICL™) for vision correction, today highlighted commentary from ...
Morningstar

Broadwood Partners Questions Integrity of STAAR Surgical’s Last-Minute Forecast Change and Fairness Opinion in Sale to Alcon

As STAAR’s largest shareholder and one of the Company’s most committed investors for more than 30 years, we are strong believers in STAAR’s opportunity to deliver significant and enduring value for ...
Reuters

ISS recommends Staar shareholders reject Alcon's $1.5 billion offer

Oct 15 (Reuters) - Proxy advisory firm Institutional Shareholder Services on Wednesday recommended that investors in Staar Surgical (STAA.O), opens new tab reject an offer by Swiss eyecare giant Alcon ...

Staar Surgical adjourns vote on acquisition by Alcon

Staar Surgical has adjourned its shareholder vote on Swiss eyecare giant Alcon's $1.5 billion takeover offer until November 6, the company said on Thursday.